ELV - Elevance Health, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 110.28B
Enterprise Value 125.60B
Trailing P/E 18.04
Forward P/E 14.16
PEG Ratio (5 yr expected) 1.13
Price/Sales (ttm)0.70
Price/Book (mrq)2.95
Enterprise Value/Revenue 0.78
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.85
52-Week Change 3-5.84%
S&P500 52-Week Change 32.74%
52 Week High 3549.52
52 Week Low 3438.56
50-Day Moving Average 3463.68
200-Day Moving Average 3484.21

Share Statistics

Avg Vol (3 month) 31.13M
Avg Vol (10 day) 31.22M
Shares Outstanding 5237.06M
Implied Shares Outstanding 6N/A
Float 8236.63M
% Held by Insiders 10.21%
% Held by Institutions 192.75%
Shares Short (May 14, 2023) 41.84M
Short Ratio (May 14, 2023) 41.71
Short % of Float (May 14, 2023) 40.78%
Short % of Shares Outstanding (May 14, 2023) 40.78%
Shares Short (prior month Apr 13, 2023) 41.64M

Dividends & Splits

Forward Annual Dividend Rate 45.92
Forward Annual Dividend Yield 41.27%
Trailing Annual Dividend Rate 35.32
Trailing Annual Dividend Yield 31.19%
5 Year Average Dividend Yield 41.11
Payout Ratio 420.63%
Dividend Date 3Jun 22, 2023
Ex-Dividend Date 4Jun 07, 2023
Last Split Factor 22:1
Last Split Date 3May 31, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 3.87%
Operating Margin (ttm)5.62%

Management Effectiveness

Return on Assets (ttm)5.39%
Return on Equity (ttm)16.99%

Income Statement

Revenue (ttm)160.68B
Revenue Per Share (ttm)672.21
Quarterly Revenue Growth (yoy)10.70%
Gross Profit (ttm)40.11B
Net Income Avi to Common (ttm)6.22B
Diluted EPS (ttm)25.78
Quarterly Earnings Growth (yoy)11.20%

Balance Sheet

Total Cash (mrq)38.17B
Total Cash Per Share (mrq)161.02
Total Debt (mrq)26.37B
Total Debt/Equity (mrq)70.40
Current Ratio (mrq)1.43
Book Value Per Share (mrq)157.54

Cash Flow Statement

Operating Cash Flow (ttm)12.33B
Levered Free Cash Flow (ttm)9.2B